EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

SFM Fetal Therapy Practice Guidelines: Fetal Reduction

Sangeeta Gupta

Journal of Fetal Medicine · 01.12.2023 · 10 (04) · 164-166

DOI: 10.1055/s-0044-1778737 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Fetal Medicine, erschienen am 01.12.2023. Verfasst von Sangeeta Gupta. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The indications of fetal reduction can be multifetal reduction (MFR) or selective fetal reduction. In MFR, the objective is to reduce the number of fetuses, whereas in selective fetal reduction the abnormal fetus is targeted for reduction. Reduction in the monochorionic twin pairs resulted in the most favorable pregnancy outcome among triplets and should be recommended whenever fetal reduction is an option. Selective termination by potassium chloride injection is contraindicated with monochorionic gestations because death of the unaffected twin occurs in 80 to 100% of cases. The standard operating procedures discuss various aspects of fetal reduction in detail like indications, consent, procedural details, risks and complications, and follow-up. It also gives a report template that can be used in your clinical practice.

Zitieren

APA

Gupta, S. (2023). SFM Fetal Therapy Practice Guidelines: Fetal Reduction. Journal of Fetal Medicine, 10(04), 164-166. https://doi.org/10.1055/s-0044-1778737

Vancouver

Gupta S. SFM Fetal Therapy Practice Guidelines: Fetal Reduction. Journal of Fetal Medicine. 2023;10(04):164-166. doi:10.1055/s-0044-1778737

BibTeX
@article{Gupta2023,
  author = {Gupta, Sangeeta},
  title = {SFM Fetal Therapy Practice Guidelines: Fetal Reduction},
  journal = {Journal of Fetal Medicine},
  year = {2023},
  volume = {10},
  number = {04},
  pages = {164--166},
  doi = {10.1055/s-0044-1778737}
}
Kostenlos starten →